United States Cyclophosphamide Market Report & Forecast 2021-2027

United States Cyclophosphamide Market Report & Forecast 2021-2027

Table of Contents
1 Introduction to Research & Analysis Reports
1.1 Cyclophosphamide Market Definition
1.2 Market Segments
1.2.1 Segment by Type
1.2.2 Segment by Application
1.3 United States Cyclophosphamide Market Overview
1.4 Methodology & Sources of Information
1.4.1 Research Methodology
1.4.2 Research Process
1.4.3 Base Year
2 United States Cyclophosphamide Overall Market Size
2.1 United States Cyclophosphamide Market Size: 2021 VS 2027
2.2 United States Cyclophosphamide Revenue, Prospects & Forecasts: 2016-2027
2.3 United States Cyclophosphamide Sales: 2016-2027
3 Company Landscape
3.1 Top Cyclophosphamide Players in United States Market
3.2 Top United States Cyclophosphamide Companies Ranked by Revenue
3.3 United States Cyclophosphamide Revenue by Companies
3.4 United States Cyclophosphamide Sales by Companies
3.5 United States Cyclophosphamide Price by Manufacturer (2016-2021)
3.6 Top 3 and Top 5 Cyclophosphamide Companies in United States Market, by Revenue in 2020
3.7 Manufacturers Cyclophosphamide Product Type
3.8 Tier 1, Tier 2 and Tier 3 Cyclophosphamide Players in United States Market
3.8.1 List of Tier 1 Cyclophosphamide Companies in United States
3.8.2 List of Tier 2 and Tier 3 Cyclophosphamide Companies in United States
4 Sights by Type
4.1 Overview
4.1.1 By Type - United States Cyclophosphamide Market Size Markets, 2021 & 2027
4.1.2 High-Dose
4.1.3 Low-Dose
4.2 By Type - United States Cyclophosphamide Revenue & Forecasts
4.2.1 By Type - United States Cyclophosphamide Revenue, 2016-2021
4.2.2 By Type - United States Cyclophosphamide Revenue, 2022-2027
4.2.3 By Type - United States Cyclophosphamide Revenue Market Share, 2016-2027
4.3 By Type - United States Cyclophosphamide Sales & Forecasts
4.3.1 By Type - United States Cyclophosphamide Sales, 2016-2021
4.3.2 By Type - United States Cyclophosphamide Sales, 2022-2027
4.3.3 By Type - United States Cyclophosphamide Sales Market Share, 2016-2027
4.4 By Type - United States Cyclophosphamide Price (Manufacturers Selling Prices), 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - United States Cyclophosphamide Market Size, 2021 & 2027
5.1.2 Cancer
5.1.3 Autoimmune Diseases
5.1.4 AL Amyloidosis
5.1.5 Others
5.2 By Application - United States Cyclophosphamide Revenue & Forecasts
5.2.1 By Application - United States Cyclophosphamide Revenue, 2016-2021
5.2.2 By Application - United States Cyclophosphamide Revenue, 2022-2027
5.2.3 By Application - United States Cyclophosphamide Revenue Market Share, 2016-2027
5.3 By Application - United States Cyclophosphamide Sales & Forecasts
5.3.1 By Application - United States Cyclophosphamide Sales, 2016-2021
5.3.2 By Application - United States Cyclophosphamide Sales, 2022-2027
5.3.3 By Application - United States Cyclophosphamide Sales Market Share, 2016-2027
5.4 By Application - United States Cyclophosphamide Price (Manufacturers Selling Prices), 2016-2027
6 Manufacturers & Brands Profiles
6.1 Baxter
6.1.1 Baxter Corporation Information
6.1.2 Baxter Overview
6.1.3 Baxter Cyclophosphamide Sales and Revenue in United States Market (2016-2021)
6.1.4 Baxter Cyclophosphamide Product Description
6.1.5 Baxter Recent Developments
6.2 Novartis
6.2.1 Novartis Corporation Information
6.2.2 Novartis Overview
6.2.3 Novartis Cyclophosphamide Sales and Revenue in United States Market (2016-2021)
6.2.4 Novartis Cyclophosphamide Product Description
6.2.5 Novartis Recent Developments
6.3 Hikma Pharmaceuticals
6.3.1 Hikma Pharmaceuticals Corporation Information
6.3.2 Hikma Pharmaceuticals Overview
6.3.3 Hikma Pharmaceuticals Cyclophosphamide Sales and Revenue in United States Market (2016-2021)
6.3.4 Hikma Pharmaceuticals Cyclophosphamide Product Description
6.3.5 Hikma Pharmaceuticals Recent Developments
6.4 Amneal Pharmaceuticals LLC
6.4.1 Amneal Pharmaceuticals LLC Corporation Information
6.4.2 Amneal Pharmaceuticals LLC Overview
6.4.3 Amneal Pharmaceuticals LLC Cyclophosphamide Sales and Revenue in United States Market (2016-2021)
6.4.4 Amneal Pharmaceuticals LLC Cyclophosphamide Product Description
6.4.5 Amneal Pharmaceuticals LLC Recent Developments
6.5 Jiangsu Hengrui Medicine
6.5.1 Jiangsu Hengrui Medicine Corporation Information
6.5.2 Jiangsu Hengrui Medicine Overview
6.5.3 Jiangsu Hengrui Medicine Cyclophosphamide Sales and Revenue in United States Market (2016-2021)
6.5.4 Jiangsu Hengrui Medicine Cyclophosphamide Product Description
6.5.5 Jiangsu Hengrui Medicine Recent Developments
6.6 NorthStar Rx LLC
6.6.1 NorthStar Rx LLC Corporation Information
6.6.2 NorthStar Rx LLC Overview
6.6.3 NorthStar Rx LLC Cyclophosphamide Sales and Revenue in United States Market (2016-2021)
6.6.4 NorthStar Rx LLC Cyclophosphamide Product Description
6.6.5 NorthStar Rx LLC Recent Developments
6.7 GLS Pharma
6.7.1 GLS Pharma Corporation Information
6.7.2 GLS Pharma Overview
6.7.3 GLS Pharma Cyclophosphamide Sales and Revenue in United States Market (2016-2021)
6.7.4 GLS Pharma Cyclophosphamide Product Description
6.7.5 GLS Pharma Recent Developments
6.8 CSC Pharmaceuticals International
6.8.1 CSC Pharmaceuticals International Corporation Information
6.8.2 CSC Pharmaceuticals International Overview
6.8.3 CSC Pharmaceuticals International Cyclophosphamide Sales and Revenue in United States Market (2016-2021)
6.8.4 CSC Pharmaceuticals International Cyclophosphamide Product Description
6.8.5 CSC Pharmaceuticals International Recent Developments
7 United States Cyclophosphamide Production Capacity, Analysis
7.1 United States Cyclophosphamide Production Capacity, 2016-2027
7.2 Cyclophosphamide Production Capacity of Key Manufacturers in United States Market
8 Key Market Trends, Opportunity, Drivers and Restraints
8.1 Market Opportunities & Trends
8.2 Market Drivers
8.3 Market Restraints
9 Cyclophosphamide Supply Chain Analysis
9.1 Cyclophosphamide Industry Value Chain
9.2 Cyclophosphamide Upstream Market
9.3 Cyclophosphamide Downstream and Clients
9.4 Marketing Channels Analysis
9.4.1 Marketing Channels
9.4.2 Cyclophosphamide Distributors and Sales Agents in United States Market
10 Conclusion
11 Appendix
11.1 Note
11.2 Examples of Clients
11.3 Author Details
11.4 Disclaimer
List of Tables
Table 1. Key Players of Cyclophosphamide in United States Market
Table 2. Top Cyclophosphamide Players in United States Market, Ranking by Revenue (2019)
Table 3. United States Cyclophosphamide Revenue by Companies, (US$, Mn), 2016-2021
Table 4. United States Cyclophosphamide Revenue Share by Companies, 2016-2021
Table 5. United States Cyclophosphamide Sales by Companies, (Person), 2016-2021
Table 6. United States Cyclophosphamide Sales Share by Companies, 2016-2021
Table 7. Key Manufacturers Cyclophosphamide Price (2016-2021) & (Average Cost/Person)
Table 8. Manufacturers Cyclophosphamide Product Type
Table 9. List of Tier 1 Cyclophosphamide Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Tier 2 and Tier 3 Cyclophosphamide Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. Major Manufacturers of High-Dose
Table 12. Major Manufacturers of Low-Dose
Table 13. By Type - United States Cyclophosphamide Revenue, (US$, Mn), 2021 & 2027
Table 14. By Type - United States Cyclophosphamide Revenue (US$, Mn), 2016-2021
Table 15. By Type - United States Cyclophosphamide Revenue (US$, Mn), 2022-2027
Table 16. By Type - United States Cyclophosphamide Sales (Person), 2016-2021
Table 17. By Type - United States Cyclophosphamide Sales (Person), 2022-2027
Table 18. By Application - United States Cyclophosphamide Revenue, (US$, Mn), 2021 VS 2027
Table 19. By Application - United States Cyclophosphamide Revenue (US$, Mn), 2016-2021
Table 20. By Application - United States Cyclophosphamide Revenue (US$, Mn), 2022-2027
Table 21. By Application - United States Cyclophosphamide Sales (Person), 2016-2021
Table 22. By Application - United States Cyclophosphamide Sales (Person), 2022-2027
Table 23. Baxter Corporation Information
Table 24. Baxter Description and Major Businesses
Table 25. Baxter Cyclophosphamide Sales (Person), Revenue (US$, Mn) and Gross Margin (Average Cost/Person) (2016-2021)
Table 26. Baxter Cyclophosphamide Product
Table 27. Baxter Recent Developments
Table 28. Novartis Corporation Information
Table 29. Novartis Description and Major Businesses
Table 30. Novartis Cyclophosphamide Sales (Person), Revenue (US$, Mn) and Gross Margin (Average Cost/Person) (2016-2021)
Table 31. Novartis Cyclophosphamide Product
Table 32. Novartis Recent Developments
Table 33. Hikma Pharmaceuticals Corporation Information
Table 34. Hikma Pharmaceuticals Description and Major Businesses
Table 35. Hikma Pharmaceuticals Cyclophosphamide Sales (Person), Revenue (US$, Mn) and Gross Margin (Average Cost/Person) (2016-2021)
Table 36. Hikma Pharmaceuticals Cyclophosphamide Product
Table 37. Hikma Pharmaceuticals Recent Developments
Table 38. Amneal Pharmaceuticals LLC Corporation Information
Table 39. Amneal Pharmaceuticals LLC Description and Major Businesses
Table 40. Amneal Pharmaceuticals LLC Cyclophosphamide Sales (Person), Revenue (US$, Mn) and Gross Margin (Average Cost/Person) (2016-2021)
Table 41. Amneal Pharmaceuticals LLC Cyclophosphamide Product
Table 42. Amneal Pharmaceuticals LLC Recent Developments
Table 43. Jiangsu Hengrui Medicine Corporation Information
Table 44. Jiangsu Hengrui Medicine Description and Major Businesses
Table 45. Jiangsu Hengrui Medicine Cyclophosphamide Sales (Person), Revenue (US$, Mn) and Gross Margin (Average Cost/Person) (2016-2021)
Table 46. Jiangsu Hengrui Medicine Cyclophosphamide Product
Table 47. Jiangsu Hengrui Medicine Recent Developments
Table 48. NorthStar Rx LLC Corporation Information
Table 49. NorthStar Rx LLC Description and Major Businesses
Table 50. NorthStar Rx LLC Cyclophosphamide Sales (Person), Revenue (US$, Mn) and Gross Margin (Average Cost/Person) (2016-2021)
Table 51. NorthStar Rx LLC Cyclophosphamide Product
Table 52. NorthStar Rx LLC Recent Developments
Table 53. GLS Pharma Corporation Information
Table 54. GLS Pharma Description and Major Businesses
Table 55. GLS Pharma Cyclophosphamide Sales (Person), Revenue (US$, Mn) and Gross Margin (Average Cost/Person) (2016-2021)
Table 56. GLS Pharma Cyclophosphamide Product
Table 57. GLS Pharma Recent Developments
Table 58. CSC Pharmaceuticals International Corporation Information
Table 59. CSC Pharmaceuticals International Description and Major Businesses
Table 60. CSC Pharmaceuticals International Cyclophosphamide Sales (Person), Revenue (US$, Mn) and Gross Margin (Average Cost/Person) (2016-2021)
Table 61. CSC Pharmaceuticals International Cyclophosphamide Product
Table 62. CSC Pharmaceuticals International Recent Developments
Table 63. Cyclophosphamide Production Capacity (Person) of Key Manufacturers in United States Market, 2019-2021 (Person)
Table 64. United States Cyclophosphamide Capacity Market Share of Key Manufacturers, 2019-2021
Table 65. Cyclophosphamide Market Opportunities & Trends in United States Market
Table 66. Cyclophosphamide Market Drivers in United States Market
Table 67. Cyclophosphamide Market Restraints in United States Market
Table 68. Cyclophosphamide Raw Materials
Table 69. Cyclophosphamide Raw Materials Suppliers in United States Market
Table 70. Typical Cyclophosphamide Downstream
Table 71. Cyclophosphamide Downstream Clients in United States Market
Table 72. Cyclophosphamide Distributors and Sales Agents in United States Market
List of Figures
Figure 1. Cyclophosphamide Product Picture
Figure 2. Cyclophosphamide Segment by Type
Figure 3. Cyclophosphamide Segment by Application
Figure 4. United States Cyclophosphamide Market Overview: 2020
Figure 5. United States Cyclophosphamide Market Size: 2021 VS 2027 (US$, Mn)
Figure 6. United States Cyclophosphamide Revenue, 2016-2027 (US$, Mn)
Figure 7. Cyclophosphamide Sales in United States Market: 2016-2027 (Person)
Figure 8. The Top 3 and 5 Players Market Share by Cyclophosphamide Revenue in 2020
Figure 9. High-Dose Product Picture
Figure 10. Low-Dose Product Picture
Figure 11. By Type - United States Cyclophosphamide Sales Market Share, 2016-2027
Figure 12. By Type - United States Cyclophosphamide Revenue Market Share, 2016-2027
Figure 13. By Type - United States Cyclophosphamide Price (Average Cost/Person), 2016-2027
Figure 14. Cancer
Figure 15. Autoimmune Diseases
Figure 16. AL Amyloidosis
Figure 17. Others
Figure 18. By Application - United States Cyclophosphamide Sales Market Share, 2016-2027
Figure 19. By Application - United States Cyclophosphamide Revenue Market Share, 2016-2027
Figure 20. By Application - United States Cyclophosphamide Price (Average Cost/Person), 2016-2027
Figure 21. Baxter Cyclophosphamide Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 22. Novartis Cyclophosphamide Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 23. Hikma Pharmaceuticals Cyclophosphamide Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 24. Amneal Pharmaceuticals LLC Cyclophosphamide Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 25. Jiangsu Hengrui Medicine Cyclophosphamide Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 26. NorthStar Rx LLC Cyclophosphamide Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 27. GLS Pharma Cyclophosphamide Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 28. CSC Pharmaceuticals International Cyclophosphamide Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 29. United States Cyclophosphamide Production Capacity (Person), 2016-2027
Figure 30. Cyclophosphamide Industry Value Chain
Figure 31. Marketing Channels

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global 5-Fluorouracil Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 76

The global 5-Fluorouracil market was valued at US$ 283 million in 2023 and is anticipated to reach US$ 487.9 million by 2030, witnessing a CAGR of 4.3% during The forecast period 2024-2030. North American market for 5-Fluorouracil is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for 5-Fluorouracil is estimated to increase from $ million in 2023 to reach $ million by ......

Global Carboplatin Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 79

The global Carboplatin market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Carboplatin is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Carboplatin is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % d......

Global Neutropenia Drugs Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 96

The global Neutropenia Drugs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated to increa......

Global Small Molecule Cancer Drug Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Small Molecule Cancer Drug market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated ......

Global Capecitabine Market Research Report 2024

Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 80

Capecitabine is an orally-administered chemotherapeutic agent used in The treatment of metastatic breast and colorectal cancers. Capecitabine is a prodrug, which is enzymatically converted to fluorouracil (antimetabolite) in The tumor, where it inhibits DNA synthesis and slows growth of tumor tissue. Common side effects include abdominal pain, vomiting, diarrhea, weakness, and rashes. Other severe side effects include blood clotting problems, allergic reactions, heart problems, and low blo......

Global Oxaliplatin Market Research Report 2024

Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 104

Oxaliplatin is a platinum-based anticancer drug with colorless or nearly colorless transparent liquid. It is often used for metastatic colorectal cancer treatment or adjuvant therapy The third stage colon cancer after resecting primary tumor completely. In this report, only The finished drug is covered, exclude API. The global Oxaliplatin market was valued at US$ 897.5 million in 2023 and is anticipated to reach US$ 1641.5 million by 2030, witnessing a CAGR of 8.9% duri......

Global Cancer Treatment Drugs Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 158

According to our LPI (LP Information) latest study, the global Cancer Treatment Drugs market size was valued at US$ 174990 million in 2023. With growing demand in downstream market, the Cancer Treatment Drugs is forecast to a readjusted size of US$ 322540 million by 2030 with a CAGR of 9.1% during review period. The research report highlights the growth potential of the global Cancer Treatment Drugs market. Cancer Treatment Drugs are expected to show stable growth in the future market. H......

Global Capecitabine Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 93

According to our LPI (LP Information) latest study, the global Capecitabine market size was valued at US$ 1003.9 million in 2023. With growing demand in downstream market, the Capecitabine is forecast to a readjusted size of US$ 975.1 million by 2030 with a CAGR of -0.4% during review period. The research report highlights the growth potential of the global Capecitabine market. Capecitabine are expected to show stable growth in the future market. However, product differentiation, reducin......

Global Methotrexate Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 95

According to our LPI (LP Information) latest study, the global Methotrexate market size was valued at US$ 506 million in 2023. With growing demand in downstream market, the Methotrexate is forecast to a readjusted size of US$ 613.9 million by 2030 with a CAGR of 2.8% during review period. The research report highlights the growth potential of the global Methotrexate market. Methotrexate are expected to show stable growth in the future market. However, product differentiation, reducing co......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs